Polyplus-transfection
Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation
Premium
The issue may lie in how the same data is analyzed to construct different PRS, posing a challenge for using and discussing the risk scores in the clinic.
Polyplus-transfection Enters Reagent Deal with Roche Glycart
The licensing deal grants Roche Glycart access to polyethylenimine for in vitro transfection applications for research purposes.
The company said it will use the funds to advance new siRNA delivery compounds and add 10 new researchers and lab technicians.
Polyplus-transfection Raises $3.2M
The company plans to use the funding to enhance its R&D resources and to hire new researchers and lab technicians.